Björn Hackanson

3.1k total citations
51 papers, 1.7k citations indexed

About

Björn Hackanson is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Björn Hackanson has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 27 papers in Hematology and 13 papers in Oncology. Recurrent topics in Björn Hackanson's work include Acute Myeloid Leukemia Research (25 papers), Epigenetics and DNA Methylation (23 papers) and Histone Deacetylase Inhibitors Research (11 papers). Björn Hackanson is often cited by papers focused on Acute Myeloid Leukemia Research (25 papers), Epigenetics and DNA Methylation (23 papers) and Histone Deacetylase Inhibitors Research (11 papers). Björn Hackanson collaborates with scholars based in Germany, United States and France. Björn Hackanson's co-authors include Michael Lübbert, Manfred Jung, Julia M. Wagner, Christoph Plass, Michael Daskalakis, Rainer Claus, Romulo Martin Brena, Claudia Schmoor, Konstanze Döhner and Carlo Stresemann and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Björn Hackanson

50 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Björn Hackanson 1.2k 583 341 197 183 51 1.7k
Akihide Yoshimi 994 0.8× 683 1.2× 231 0.7× 244 1.2× 229 1.3× 64 1.6k
Mack Mabry 1.2k 1.0× 611 1.0× 534 1.6× 139 0.7× 111 0.6× 31 1.8k
Andrew G. Muntean 1.8k 1.4× 715 1.2× 160 0.5× 190 1.0× 187 1.0× 38 2.1k
S. Tiong Ong 1.1k 0.9× 501 0.9× 297 0.9× 180 0.9× 196 1.1× 56 1.8k
Esther A. Obeng 1.2k 1.0× 584 1.0× 303 0.9× 146 0.7× 252 1.4× 33 1.8k
Tobias Berg 856 0.7× 402 0.7× 211 0.6× 116 0.6× 160 0.9× 60 1.3k
Goro Sashida 2.0k 1.6× 1.1k 1.9× 390 1.1× 267 1.4× 287 1.6× 88 2.7k
Galinos Fanourakis 1.6k 1.3× 816 1.4× 745 2.2× 243 1.2× 144 0.8× 27 2.0k
Kumiko Goi 665 0.5× 341 0.6× 356 1.0× 178 0.9× 191 1.0× 78 1.2k
Miranda Buitenhuis 506 0.4× 391 0.7× 431 1.3× 143 0.7× 378 2.1× 30 1.3k

Countries citing papers authored by Björn Hackanson

Since Specialization
Citations

This map shows the geographic impact of Björn Hackanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Hackanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Hackanson more than expected).

Fields of papers citing papers by Björn Hackanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Hackanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Hackanson. The network helps show where Björn Hackanson may publish in the future.

Co-authorship network of co-authors of Björn Hackanson

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Hackanson. A scholar is included among the top collaborators of Björn Hackanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Hackanson. Björn Hackanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Konrad, Maik, et al.. (2024). Alterations in Peripheral Lymphocyte Subsets under Immunochemotherapy in Stage IV SCLC Patients: Th17 Cells as Potential Early Predictive Biomarker for Response. International Journal of Molecular Sciences. 25(10). 5056–5056. 3 indexed citations
3.
Greve, Gabriele, Geoffroy Andrieux, Pascal Schlosser, et al.. (2023). In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts. Leukemia. 37(5). 1018–1027. 2 indexed citations
4.
Girard, N., Martin Wermke, Fabrice Barlési, et al.. (2020). 533MO Phase Ib study of BI 836880, a VEGF/Ang2-blocking nanobody®, in combination with BI 754091, an anti-PD-1 antibody: Initial results in patients (pts) with solid tumours. Annals of Oncology. 31. S467–S467. 2 indexed citations
5.
Becker, Heiko, Dietmar Pfeifer, Gabriele Ihorst, et al.. (2020). Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia. Annals of Hematology. 99(7). 1551–1560. 11 indexed citations
6.
Schmoor, Claudia, Verena I. Gaidzik, Nadja Blagitko‐Dorfs, et al.. (2017). Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy. Annals of Hematology. 96(4). 559–565. 19 indexed citations
7.
Wehrle, Julius, Rainer Claus, Heiko Becker, et al.. (2017). The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia. Experimental Hematology. 55. 76–85.e3. 3 indexed citations
8.
Finke, Jürgen, Claudia Schmoor, Hartmut Bertz, et al.. (2016). Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 51(6). 771–777. 23 indexed citations
9.
Krohn, Alexander, Theresa D. Ahrens, Till Plönes, et al.. (2014). Tumor Cell Heterogeneity in Small Cell Lung Cancer (SCLC): Phenotypical and Functional Differences Associated with Epithelial-Mesenchymal Transition (EMT) and DNA Methylation Changes. PLoS ONE. 9(6). e100249–e100249. 52 indexed citations
10.
Blagitko‐Dorfs, Nadja, Yi Jiang, Jesús Duque‐Afonso, et al.. (2013). Epigenetic Priming of AML Blasts for All-trans Retinoic Acid-Induced Differentiation by the HDAC Class-I Selective Inhibitor Entinostat. PLoS ONE. 8(10). e75258–e75258. 21 indexed citations
11.
Claus, Rainer, Dietmar Pfeifer, Manuela Zucknick, et al.. (2012). Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia. Leukemia Research. 37(2). 190–196. 21 indexed citations
12.
Hackanson, Björn & Michael Lübbert. (2011). Epigenetische Modifikationen in malignen Zellen. DMW - Deutsche Medizinische Wochenschrift. 136(10). 475–479. 1 indexed citations
13.
Claus, Rainer, Björn Hackanson, Anna R. Poetsch, et al.. (2011). Quantitative analyses of DAPK1 methylation in AML and MDS. International Journal of Cancer. 131(2). E138–42. 30 indexed citations
14.
Lübbert, Michael, Björn Rüter, Rainer Claus, et al.. (2011). A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy. Haematologica. 97(3). 393–401. 172 indexed citations
15.
Hackanson, Björn & Cornelius F. Waller. (2010). Long-term follow-up of patients with chronic myeloid leukemia having received autologous stem cell transplantation. Annals of Hematology. 90(4). 395–399. 6 indexed citations
16.
Daskalakis, Michael, Nadja Blagitko‐Dorfs, & Björn Hackanson. (2009). Decitabine. Recent results in cancer research. 184. 131–157. 37 indexed citations
17.
Whitman, Susan P., Björn Hackanson, Sandya Liyanarachchi, et al.. (2008). DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood. 112(5). 2013–2016. 56 indexed citations
18.
Hackanson, Björn, Kristi L. Bennett, Romulo Martin Brena, et al.. (2008). Epigenetic Modification of CCAAT/Enhancer Binding Protein α Expression in Acute Myeloid Leukemia. Cancer Research. 68(9). 3142–3151. 114 indexed citations
19.
Bennett, Kristi L., Björn Hackanson, Laura T. Smith, et al.. (2007). Tumor Suppressor Activity of CCAAT/Enhancer Binding Protein α Is Epigenetically Down-regulated in Head and Neck Squamous Cell Carcinoma. Cancer Research. 67(10). 4657–4664. 74 indexed citations
20.
Rosenbauer, Frank, Bronwyn M. Owens, Li Yu, et al.. (2005). Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nature Genetics. 38(1). 27–37. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihide Yoshimi Breakdown of academic impact, for papers by Mack Mabry Breakdown of academic impact, for papers by Andrew G. Muntean Breakdown of academic impact, for papers by S. Tiong Ong Breakdown of academic impact, for papers by Esther A. Obeng Breakdown of academic impact, for papers by Tobias Berg Breakdown of academic impact, for papers by Goro Sashida Breakdown of academic impact, for papers by Galinos Fanourakis Breakdown of academic impact, for papers by Kumiko Goi Breakdown of academic impact, for papers by Miranda Buitenhuis
Rankless by CCL
2026